Bio-informational futures: The convergence of artificial intelligence and synthetic biology.

Clicks: 392
ID: 94782
2020
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #1 of 8 articles by views in EMBO reports

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Synthetic biology and artificial intelligence naturally converge in the biofoundry. Navigating the ethical and societal issues of the biofoundry's potential remains a major challenge.
Reference Key
a-dixon2020bioinformationalembo Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors A Dixon, Thom;C Curach, Natalie;Pretorius, Isak S;
Journal EMBO reports
Year 2020
DOI
10.15252/embr.202050036
URL
Keywords
gemcitabine pharmacokinetics global sensitivity analysis systems pharmacology metabolic network pbpk dfdc dfdctp multiscale-model

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.